Delivery Systems and Local Administration Routes for Therapeutic siRNA

被引:87
作者
Moura de Carvalho Vicentini, Fabiana Testa [1 ]
Borgheti-Cardoso, Livia Neves [1 ]
Depieri, Livia Vieira [1 ]
Mano, Danielle de Macedo [1 ]
Abelha, Thais Fedatto [1 ]
Petrilli, Raquel [1 ]
Lopes Badra Bentley, Maria Vitoria [1 ]
机构
[1] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14040903 Ribeirao Preto, SP, Brazil
关键词
delivery systems; local administration routes; siRNA; SMALL INTERFERING RNA; SINGLE-CELL ELECTROPORATION; OF-THE-ART; DRUG-DELIVERY; GENE-EXPRESSION; ANTISENSE OLIGONUCLEOTIDES; OCULAR NEOVASCULARIZATION; INTRACELLULAR DELIVERY; DENDRITIC CELLS; ALOPECIA-AREATA;
D O I
10.1007/s11095-013-0971-1
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
With the increasing number of studies proposing new and optimal delivery strategies for the efficacious silencing of gene-related diseases by the local administration of siRNAs, the present review aims to provide a broad overview of the most important and latest developments of non-viral siRNA delivery systems for local administration. Moreover, the main disease targets for the local delivery of siRNA to specific tissues or organs, including the skin, the lung, the eye, the nervous system, the digestive system and the vagina, were explored.
引用
收藏
页码:915 / 931
页数:17
相关论文
共 136 条
[1]   Toxicogenomics of non-viral drug delivery systems for RNAi: Potential impact on siRNA-mediated gene silencing activity and specificity [J].
Akhtar, Saghir ;
Benter, Ibrahim .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :164-182
[2]   RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy [J].
Alvarez, Rene ;
Elbashir, Sayda ;
Borland, Todd ;
Toudjarska, Ivanka ;
Hadwiger, Philipp ;
John, Mathias ;
Roehl, Ingo ;
Morskaya, Svetlana Shulga ;
Martinello, Rick ;
Kahn, Jeffrey ;
Van Ranst, Mark ;
Tripp, Ralph A. ;
DeVincenzo, John P. ;
Pandey, Rajendra ;
Maier, Martin ;
Nechev, Lubomir ;
Manoharan, Muthiah ;
Kotelianski, Victor ;
Meyers, Rachel .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (09) :3952-3962
[3]   Electrically assisted ocular gene therapy [J].
Bejjani, Riad Antoine ;
Andrieu, Charlotte ;
Bloquel, Carole ;
Berdugo, Marianne ;
BenEzra, David ;
Behar-Cohen, Francine .
SURVEY OF OPHTHALMOLOGY, 2007, 52 (02) :196-208
[4]   An Eye-opener for RNAi Therapeutics [J].
Berkhout, Ben .
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2008, 107 (10) :749-750
[5]   Inhibition of respiratory viruses by nasally administered siRNA [J].
Bitko, V ;
Musiyenko, A ;
Shulyayeva, O ;
Barik, S .
NATURE MEDICINE, 2005, 11 (01) :50-55
[6]   Non-viral ocular gene therapy: Potential ocular therapeutic avenues [J].
Bloquel, C. ;
Bourges, J. L. ;
Touchard, E. ;
Berdugo, M. ;
BenEzra, D. ;
Behar-Cohen, F. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (11) :1224-1242
[7]  
Boado Ruben J, 2005, NeuroRx, V2, P139, DOI 10.1007/BF03206650
[8]   Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems [J].
Bodor, N ;
Buchwald, P .
AAPS JOURNAL, 2005, 7 (04) :E820-E833
[9]   MMP-9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier [J].
Bonoiu, Adela ;
Mahajan, Supriya D. ;
Ye, Ling ;
Kumar, Rajiv ;
Ding, Hong ;
Yong, Ken-Tye ;
Roy, Indrajit ;
Aalinkeel, Ravikumar ;
Nair, Bindukumar ;
Reynolds, Jessica L. ;
Sykes, Donald E. ;
Imperiale, Marco A. ;
Bergey, Earl J. ;
Schwartz, Stanley A. ;
Prasad, Paras N. .
BRAIN RESEARCH, 2009, 1282 :142-155
[10]   Recent developments in ocular gene therapy [J].
Borrás, T .
EXPERIMENTAL EYE RESEARCH, 2003, 76 (06) :643-652